REGN vs S · P/E 14, rev $14.34B vs rev $821.5M
Regeneron Pharmaceuticals Inc (REGN) versus SentinelOne Inc (S) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
SentinelOne Inc (S) is a software - infrastructure company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported S revenue for 2025-01-31 was $821.5M. Net income was -$288.4M. Revenue was up 32.2% from 2024-01-31 to 2025-01-31. S currently screens at market cap $4.99B.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. S currently screens at market cap $4.99B.
Not investment advice. Open the REGN and S stock pages for the full models.
Not investment advice.